Search - tctmd.com

Displaying 101 - 120 of 171

Sort: Relevancy | Date

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

News Daily News

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

June 16, 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

News Conference News SCAI 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Michael O'Riordan

April 28, 2021

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

News Daily News

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Michael O'Riordan

March 23, 2021

Little Improvement Seen Over Two Decades in US Racial Health Disparities

News Daily News

Little Improvement Seen Over Two Decades in US Racial Health Disparities

March 15, 2021

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

News Daily News

Cardiometabolic Diseases Contribute to Bulk of COVID-19 Hospitalizations

March 04, 2021

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

December 24, 2020

Even Low-Dose Steroids Increase the Risk of CVD

News Daily News

Even Low-Dose Steroids Increase the Risk of CVD

Michael O'Riordan

December 03, 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

News Daily News

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

September 30, 2020

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

Obesity’s Role in COVID-19 Deaths: ‘Profound’ and Independent of CVD

News Daily News

Obesity’s Role in COVID-19 Deaths: ‘Profound’ and Independent of CVD

August 14, 2020

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests

News Daily News

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests

August 03, 2020

Obesity’s Role in COVID-19 Deaths: Big Food, Slow Government to Blame?

News Daily News

Obesity’s Role in COVID-19 Deaths: Big Food, Slow Government to Blame?

June 11, 2020

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

News Conference News ACC 2020

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

March 28, 2020

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

News Daily News

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Michael O'Riordan

March 13, 2020

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

Dapagliflozin Has Benefits Across Heart Failure Subgroups

News Conference News AHA 2019

Dapagliflozin Has Benefits Across Heart Failure Subgroups

November 17, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.